Stay updated on Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial
Sign up to get notified when there's something new on the Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial page.

Latest updates to the Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial page
- Check6 days agoChange DetectedThe new screenshot shows minor layout adjustments and updated labeling, while core sections such as Study Overview, Eligibility, Design, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check35 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check42 days agoChange DetectedAdded version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several safety-focused sections. If these topics were critical, this would be a major reduction; otherwise, it appears to be a restructuring.SummaryDifference0.3%

- Check57 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. This indicates a straightforward upgrade with minor UI simplification.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check71 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous locations across various countries, particularly in Russia, Colombia, Germany, and Ukraine, as well as the introduction of new terms related to drug safety and pharmaceutical preparations. Several outdated location entries have been removed, streamlining the information presented.SummaryDifference24%

Stay in the know with updates to Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gefapixant in Women: Cough & Urinary Incontinence Clinical Trial page.